The REgistry of Very Early Estrogen and AnovuLation
Recruiting
Observational Study
Hypothalamic Amenorrhea, Functional
Hypothalamic Amenorrhea
Functional Hypogonadotropic Hypogonadism
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 – 40
- Sex
- Female
- Study type
- Observational
- Participants needed
- 100,000 (estimated)
- Sponsor
- Mayo Clinic · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The purpose of this study is to to build a registry of women with early estrogen loss due to Functional Hypothalamic Amenorrhea (FHA) to understand the prevalence, racial and ethnic diversity of this condition.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* 3 or more months of consecutive amenorrhea with a diagnosis of functional hypothalamic amenorrhea or screening hormones consistent with functional hypothalamic amenorrhea including but not limited to:
* Estradiol: \< 50pg/mL
* LH: \< 10 IU/mL
* FSH: \< 10 IU
* Testost…
Contacts